Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-CD30/TNFRSF8 Antibody-APC (9F649)
🥰Excellent
Catalog No. TMAY-01161A
Anti-CD30/TNFRSF8 Antibody-APC (9F649) is a APC-conjugated Mouse antibody targeting CD30/TNFRSF8. Anti-CD30/TNFRSF8 Antibody-APC (9F649) can be used in FCM.
Anti-CD30/TNFRSF8 Antibody-APC (9F649)
Anti-CD30/TNFRSF8 Antibody-APC (9F649)
🥰Excellent
Catalog No. TMAY-01161A
Anti-CD30/TNFRSF8 Antibody-APC (9F649) is a APC-conjugated Mouse antibody targeting CD30/TNFRSF8. Anti-CD30/TNFRSF8 Antibody-APC (9F649) can be used in FCM.
Product information is being updated, if you want to purchase, please click the bulk custom button.
Bulk & Custom
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Anti-CD30/TNFRSF8 Antibody-APC (9F649) is a APC-conjugated Mouse antibody targeting CD30/TNFRSF8. Anti-CD30/TNFRSF8 Antibody-APC (9F649) can be used in FCM. |
| Ig Type | Monoclonal Mouse IgG1 |
| Clone | 9F649 |
| Reactivity | Human |
| Verified Activity | Profile of anti-Human TNFRSF8 (CD30) reactivity on K562 cells analyzed by flow cytometry. |
| Application | FCM |
| Recommended Dose | 10 μl/Test, 0.1 mg/ml |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Construction | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CD30 / TNFRSF8 (rh CD30 / TNFRSF8; TMPY-01827; NP_001234.2; Met 1-Lys 379) and conjugated with APC under optimum conditions, the unreacted APC was removed. |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | PBS solution containing 0.5% BSA and 0.03%ProClin300 |
| Research Background | CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor (TNFR) superfamily. CD30 protein is expressed by activated, but not resting, T and B cells. CD30 can regulate proliferation of lymphocytes and may also play an important role in human immunodeficiency virus replication. As a regulator of apoptosis, CD30 protein induces cell death or proliferation, depending on the cell type, and has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. CD30 protein expression is upregulated in various hematological malignancies, including Reed-Sternberg cells in Hodgkin's disease (HD), anaplastic large cell lymphoma (ALCL) and subsets of Non-Hodgkin's lymphomas (NHLs), and CD30 is also linked to leukocytes in patients with chronic inflammatory diseases, including lupus erythematosus, asthma, rheumatoid arthritis and atopic dermatitis (AD).Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
| Conjucates | APC |
| Others Formats | Unconjugated/FITC/PE |
| Antibody Types Available | 4 |
| Immunogen | Recombinant Human CD30 / TNFRSF8 protein (TMPY-01827) |
| Antigen Species | Human |
| Biology Area | Cancer Drug Targets |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. |
| Transport | Shipping with blue ice. |
Sci Citations
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-CD30/TNFRSF8 Antibody-APC (9F649) | purchase Anti-CD30/TNFRSF8 Antibody-APC (9F649) | Anti-CD30/TNFRSF8 Antibody-APC (9F649) cost | order Anti-CD30/TNFRSF8 Antibody-APC (9F649)
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.